Liver Enzymes In Diabetic Rats Research Articles

Therapeutic role of kaempferol and myricetin in streptozotocin-induced diabetes synergistically via modulation in pancreatic amylase, glycogen storage and insulin secretion.

Kaempferol and Myricetin alone have promising benefits on diabetes and related complications, yet the effectiveness of cotreating the two compounds on diabetes have not been studied. The existing investigation was to study the combined anti-diabetic effect of kaempferol and myricetin in Streptozotocin (STZ)-activated diabetes in rats. To evaluate the anti-diabetic activity, 36 Wistar rats were segregated into six groups; Normal, 50mg/kg STZ-induced diabetes, and four (50mg/kg kaempferol, 50mg/kg myricetin, 25mg/kg kaempferol + myricetin, and 5mg/kg glibenclamide) compound-treated diabetic groups.The effects of co-treatment on parameters, glucose, insulin, lipid profile, liver enzymes, antioxidant biomarkers, and inflammatory cytokines were measured. The study revealed that combined treatment restored the assessed parameters including glucose levels, inflammatory cytokines, oxidative markers, and lipid and liver enzymes in diabetic rats. The results indicate that cotreatment of kaempferol and myricetin has a beneficial role against diabetes suggesting that cotreatment of these compounds can be used therapeutically in treating diabetes.

Citri Reticulatae Pericarpium (Chenpi) Protects against Endothelial Dysfunction and Vascular Inflammation in Diabetic Rats.

Dried tangerine peel (Citri reticulatae Pericarpium, CRP; Chenpi in Chinese) possesses medicine and food homology with hypolipidemic, anti-inflammatory and antioxidant activities. This study aimed to explore the protective effect of CRP extract on endothelial function and inflammation in type 2 diabetic rats and the related mechanisms. Type 2 diabetes mellitus was induced by high-fat diet (HFD)/streptozotocin (STZ) in male Sprague Dawley rats, and CRP extract was orally administered at 400 mg/kg/day for 4 weeks. Rat and mouse aortas were treated with high glucose and CRP extract ex vivo. The data showed that the ethanolic extract of CRP normalized blood pressure and the plasma lipid profile as well as the plasma levels of liver enzymes in diabetic rats. Impaired endothelium-dependent relaxations in aortas, carotid arteries and renal arteries were improved. CRP extract suppressed vascular inflammatory markers and induced AMPK activation in aortas of diabetic rats. Exposure to high glucose impaired vasodilation in aortas of rats and mice, and this impairment was prevented by co-incubation with CRP extract. In conclusion, our findings suggest that CRP extract protects endothelial function by inhibiting the vascular inflammatory state on activation of AMPK in diabetic rats.

Evaluation of the Effect of Ethanol Seed Extract of Telfairia. occidentalis on the Hepatic Health of Diabetic Rats.

The aim of this study was to evaluate the effect of ethanol seed extract of Telfairia. occidentalis on the activity of liver enzymes in diabetic rats. Freshly harvested seed of T. occidentalis was processed into extract. Twenty (25) adult male wistar rats were divided into five (5) groups of five rats each. Group I was fed normal rat chow and water only, Group II was diabetic; untreated rats, Groups III and IV were diabetic; treated with 150 mg/kg and 250 mg/kg extract of T. occidentalis seed. The activity of serum hepatomarkers (Aspartate transaminase, Alanine amino transaminase and Alkaline phosphatase) evaluated was significantly (P<0.05) high which was reversed in a dose dependent manner. In conclusion, it has been unveiled through this study that T. occidentalis seed extract has the potential to improve hepatic health.

Effect of Aerobic Exercise Combined With Stevia Extract Supplementation on Selected Liver Enzymes in Diabetic Rats

Objective: Diabetes is a chronic disease associated with a wide range of liver diseases. The levels of liver enzymes such as Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) are changed following a liver disease The purpose of this study is to investigate the effect of aerobic exercise combined with Stevia extract supplementation on the levels of ALT and AST enzymes in diabetic rats. Methods: In this experimental study, 40 males wistar rats weighing 150-220 g were used. Animals were randomly divided into five groups; healthy control , diabetic control, diabetic + exercise, diabetic + stevia, and diabetic + exercise + stevia. The extract was administered by oral gavage for 6 weeks. The aerobic exercise program was performed for six weeks, 5 days per week. At the end of the intervention, blood samples were collected from the heart of rats to measure the levels of ALT and AST. Data were analyzed by one-way ANOVA and Tukey’s post hoc test. Results: The levels of ALT and AST enzymes decreased significantly in all experimental groups compared to diabetic control group (P<0.05). Conclusion: Aerobic exercise combined with stevia extract supplementation can improve the liver function in streptozotocin-induced diabetic rats

Biosynthesis of Novel Silver Nanoparticles Using Eryngium thyrsoideum Boiss Extract and Comparison of their Antidiabetic Activity with Chemical Synthesized Silver Nanoparticles in Diabetic Rats.

In the present study, silver nanoparticles (1) were synthesized by green method using Eryngium campestre Boiss aqueous extract and silver nanoparticles (2) were synthesized with chemical method. The silver nanoparticles (1) and (2) were characterized with FT-IR, UV-Vis, XRD, EDX, SEM, and TEM analyses. The effects of silver nanoparticles (1) and (2) were investigated on glucose, hematology, and blood biochemical parameters in alloxan- induced diabetes type 1 model rats. Diabetic or intact rats received intraperitoneal injection of saline or 2.5mg/kg of silver nanoparticles (1) and (2) for 14 consecutive days. Hematological parameters and serum concentration of FBS, HbA1C, ALT, AST, GGT, ALP, albumin, creatinine, and urea were determined. Interestingly, silver NPs (1) or (2) did not exert toxic influences on hematological parameters and liver and kidney function in intact rats. Both silver nanoparticles (1) and (2) exert hypoglycemic effects in diabetic rats. They did not alter urea, creatinine, and hematological parameters except white blood cell (WBC) count in diabetic rats. Silver nanoparticles (1) decreased significantly liver enzyme levels including ALT and AST of diabetic rats. However silver nanoparticles (2) could not suppress the increased levels of liver enzymes in diabetic rats. In comparison with silver nanoparticles (2), the silver nanoparticles (1) are more protective than the same dose of silver nanoparticles (2) in the regulation and improving the liver function in diabetic rats. Also, silver nanoparticles (1) may exert protective effects on liver damage of diabetic rats rather than kidney damage.

Effect of Aqueous and Methanolic Extracts of Momordica charantia Fruit on Blood Glucose and Liver Enzymes in Diabetic Rats

Aims: Karela (Momordica charantia), is extensively used in traditional medicine as an antidiabetic drug. The aim of the present study was to analyze the effect of aqueous and methanolic extrarct of Momordica charantia on blood glucose and liver enzymes of rats. Materials & Methods: In this experimental study, 36 adult male Wistar rats were divided into 6 groups (6 rats in each group); control (healthy rats), negative control (diabetic rats by Streptozotocine) and 4 experimental groups (diabetic rats which recived aqueous and methanolic extracts of plant in concentrations of 50 and 100mg/kg of body weight daily for 40 days). The amount of the blood glucose was determined by sequential incision of the tip of the tail once a weak. After completing 40 days, blood was collected from heart of rats and the level of the liver enzymes serum was determined. The results were analysed by ANOVA with repeated measure and one way ANOVA tests in SPSS 19 software. Findings: The effect of different concentrations of aqueous and methanolic extracts on the blood glucose level was significant (p<0.001). Also a significant difference was observed between the amount of the aspartate aminotransfrase (p=0.049) and alanin aminotransfrase (p=0.005) enzymes activity at the two groups of negative control and 50mg/kg of body weight of methanolic extract. Using of 50 and 100mg/kg of body weight of aqueous and methanolic extracts reduced the alkalin phosphatase enzyme activity (p=0.002). Conclusion: Aqueous extract of Momordica charantia fruit have better effect on reducing the blood glucose than methanolic extracts. Both aqueous and methanolic extracts reduce the activity of aspartate aminotransfrase, alanin aminotransfrase and alkalin phosphatase.

Effects of combined leaf extract of Vernonia amygdalina and Azadirachta indica on hepatic morphology and hepatotoxicity markers in streptozotocin-induced diabetic rats

In this work, we studied liver morphology, markers of hepatic oxidative stress and some liver enzymes in diabetic rats treated with the combined leaf extract (CLE) of Vernonia amygdalina (bitter leaf) and Azadirachta indica (neem). Diabetes was induced in fasted male Wistar rats with intraperitoneal injection of streptozotocin (STZ). Oral CLE (500 mg/kg body weight) and metformin (150 mg/kg body weight) were administered to different groups of diabetic rats for eight weeks. Blood glucose and change in body weight were estimated weekly. All animals were sacrificed under anaesthesia after eight weeks. Hepatic sections were stained with periodic acid-Schiff. Liver samples were homogenized and assayed for contents of malondialdehyde (MDA) and glutathione peroxidase (GPx), while the plasma was assayed for contents of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Metformin and CLE treatment produced normoglycaemia in the diabetic rats in the course of the treatment period. Significant increases in body weight were observed in the treatment groups compared with the diabetic control rats (P<0.05). In the control and treatment groups, light microscopic study showed intact hepatic histology. Plasma ALT and AST were not significantly different from the control values in the CLE-treated rats. In addition, from week four onwards, blood glucose concentrations in the CLE-treated rats were not different from the normal control (P>0.05). Besides, hepatic MDA (P<0.05) significantly decreased in the CLE-treated rats compared with the normal control. These findings suggest that CLE ameliorates hyperglycemia and hepatic oxidative stress when administered to diabetic rats as a chronic regimen, and there was no morphologic or biochemical evidence of liver damage at the dose tested.